Patents by Inventor Christine Tober

Christine Tober has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20030186997
    Abstract: The invention relates to 2,5-dihydropyrazolo[3,4-d]pyrimidin-4-ones and their tautomers which contain in the 5-position an ar(alkyl) radical and in the 2-position a hydrogen or an ar(alkyl) radical, processes for their preparation and their use as medicaments, in particular for the treatment of epilepsy of various forms.
    Type: Application
    Filed: February 18, 2003
    Publication date: October 2, 2003
    Inventors: Thomas Arnold, Hans-Joachim Lankau, Klaus Unverferth, Christine Tober, Chris Rundfeldt, Rita Dost, Katrin Bernoster, Antje Gasparic
  • Patent number: 6500821
    Abstract: The invention relates to 1,5-dihydropyrrol-2-ones of Formula 1 which contain an aryl radical in the 1-position and a secondary amine radical in the 4-position, to a process for making and for a process to treat various forms of epilepsies and of states of anxiety and tension.
    Type: Grant
    Filed: August 31, 2000
    Date of Patent: December 31, 2002
    Assignee: Arzneimittelwerk Dresden GmbH
    Inventors: Thomas Arnold, Klaus Unverferth, Hans-Joachim Lankau, Angelika Rostock, Christine Tober, Chris Rundfeldt, Reni Bartsch
  • Patent number: 6117900
    Abstract: The invention relates to the use of 2-amino-4-(4-fluorobenzylamino)-1-ethoxycarbonylaminobenzene of formula I ##STR1## or its pharmaceutically utilizable salts, for the prophylaxis and treatment of neuropathic pain.
    Type: Grant
    Filed: September 27, 1999
    Date of Patent: September 12, 2000
    Assignee: ASTA Medica Aktiengesellschaft
    Inventors: Chris Rundfeldt, Reni Bartsch, Angelika Rostock, Christine Tober, Rita Dost
  • Patent number: 6054460
    Abstract: The invention relates to pyrazolo[3,4d]pyrimidin-4(5H)-ones and pyrazolo[3,4-d]pyrimidine-4(5H)-thiones and their tautomers and pharmaceutically acceptable salts, which contain a benzyl radical in the 2-position, processes for their preparation and their use as medicaments, in particular for the treatment of epilepsies of various forms and of allergic/asthmatic diseases.
    Type: Grant
    Filed: June 15, 1999
    Date of Patent: April 25, 2000
    Assignee: Arzneimittelwerk Dresden GmbH
    Inventors: Thomas Arnold, Hans-Joachim Lankau, Manfred Menzer, Angelika Rostock, Christine Tober, Klaus Unverferth
  • Patent number: 5994347
    Abstract: A process for the treatment of anxiety and tension, which comprises administering to a patient in need therefor an anxiolytically effective amount of a compound of the formula ##STR1## wherein X is hydrogen, a C.sub.1-4 alkyl, C.sub.1-4 alkoxy, trifluoromethyl residue, or halogen; R.sup.1 and R.sup.2 are independently of each other a C.sub.1-4 alkyl, cycloalkyl, C.sub.2-4 hydroxyalkyl, or heteroalkyl residue, or R.sup.1 and R.sup.2 together form a C.sub.2-6 alkylene residue in which one --CH.sub.2 -- group can be replaced by oxygen, nitrogen or sulfur; n is 0 or 1, and m is 0 or a cardinal number from 1-5, or a pharmaceutically acceptable salt of the compound.
    Type: Grant
    Filed: May 15, 1998
    Date of Patent: November 30, 1999
    Assignee: Arzneimittelwerk Dresden GmbH
    Inventors: Angelika Rostock, Rita Dost, Christine Tober, Reni Bartsch, Klaus Unverferth, Chris Rundfeldt
  • Patent number: 5852053
    Abstract: The use of the compound I ##STR1## or its pharmaceutically utilizable salts for the propylaxis and treatment of the squelae of chronic reduced cerebral blood supply, in particular of stroke, and for the treatment of nuerodegenerative disorders is claimed.
    Type: Grant
    Filed: October 28, 1996
    Date of Patent: December 22, 1998
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Angelika Rostock, Chris Rundfeldt, Christine Tober, Reni Bartsch
  • Patent number: 5849789
    Abstract: The use of the compound I ##STR1## or its pharmaceutically utilizable salts for the propylaxis and treatment of the sequel of chronic reduced cerebral blood supply, in particular of stroke, and for the treatment of neurodegenerative disorders is claimed.
    Type: Grant
    Filed: September 25, 1997
    Date of Patent: December 15, 1998
    Assignee: Asta Medica Aktiengesellschaft
    Inventors: Angelika Rostock, Chris Rundfeldt, Christine Tober, Reni Bartsch